Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Myeloid 1

Conditions

Myeloproliferative Disorders 5Myelodysplastic Syndromes 5Leukemia 5Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 4Primary Myelofibrosis 2Leukemia, Myelomonocytic, Chronic 2Anemia, Refractory, with Excess of Blasts 2Thrombocythemia, Essential 1Precancerous Conditions 1Polycythemia Vera 1Multiple Myeloma 1Mastocytosis, Systemic 1Leukemia, Promyelocytic, Acute 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Graft vs Host Disease 1Congenital Abnormalities 1Blast Crisis 1Anemia, Refractory 1Anemia 1

Interventions

Peripheral Blood Stem Cell Transplantation 9Cyclophosphamide 8fludarabine phosphate 7Whole-Body Irradiation 7Tacrolimus 6Mycophenolic Acid 5Busulfan 5Melphalan 4Methotrexate 3Etoposide 3Cyclosporine 3Antilymphocyte Serum 3fludarabine 2Sirolimus 2Patient Reported Outcome Measures 2Morphine 2Methylprednisolone 2Mesna 2Interferon-alpha 2Filgrastim 2Carboplatin 2Bone Marrow Transplantation 2tanespimycin 1sargramostim 1ruxolitinib 1pyroxamide 1aldesleukin 1Topotecan 1Thalidomide 1Tetradecanoylphorbol Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precancerous Conditions × Thalidomide × Myeloid × Clear all
NCT00769587 2025-09-22

Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis

Centre Hospitalier Universitaire, Amiens

Completed
MyeloidOther neoplasm

Precancerous Conditions, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡